Peptide maker to triple site with $18.8M project

A South Carolina-based peptide maker intends to spend nearly $19 million to triple the size of its plant and headquarters and has promised the state it will add 100 jobs in the next 5 years.

AmbioPharm will spend $18.8 million for a 40,000 square foot expansion at its operations in North Augusta, SC, the state commerce department said in a release. The company will build new manufacturing suites and a new world headquarters on the 32-acre site there. Work is expected to be complete by 2018. The state is providing job credits for the new project but did not state what they are worth.

It is actually the second expansion for the company. It opened its initial 10,000 square foot manufacturing facility and headquarters there in 2007. The same year, it also opened a facility in Shanghai, China, that focuses on synthesis, as well as the research and development of pharmaceutical products. AmbioPharm added about 10,000 square feet of space to the South Carolina facility last year.

South Carolina had an even larger expansion project to laud a year ago when Ritedose announced plans to invest up to $110 million in its plant in Columbia, SC. That project called for adding 80,000 square feet to an existing 120,000-square-foot facility and up to 65 jobs over 5 years. The Ritedose plant specializes in inhalation products as well as eye and ear drops, and the project will double its capacity to about 2 billion units.

- here's the release

Related Article:
Ritedose to invest up to $110M in South Carolina plant

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.